Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
通常取引
$318.39
+$1.1389 · +0.36%
日中の時刻はETです。市場データは遅延する場合があります。
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
日中レンジ
現在 $318.39
52週レンジ
現在 $318.39
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
91
大幅な割安
センチメント
60
まちまち
リスク
23
中程度のリスク
モメンタム
43
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
日中レンジ
現在 $318.39
52週レンジ
現在 $318.39
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 3213.33億 USD | 2939.59億 USD | 2621.73億 USD | 2385.87億 USD | 2139.89億 USD |
| 売上原価 | 3111.91億 USD | 2852.57億 USD | 2544.17億 USD | 2309.86億 USD | 2077.2億 USD |
| 粗利益 | 101.42億 USD | 87.01億 USD | 77.56億 USD | 76.01億 USD | 62.69億 USD |
| 販売・一般管理 | 64.94億 USD | 56.61億 USD | 53.1億 USD | 48.49億 USD | 35.94億 USD |
| 営業費用 | 64.94億 USD | 56.61億 USD | 53.1億 USD | 48.49億 USD | 35.94億 USD |
| 受取利息 | 1.28億 USD | 9169.1万 USD | 4671.9万 USD | 2130.9万 USD | 847万 USD |
| 支払利息 | 4.2億 USD | 2.49億 USD | 2.76億 USD | 2.32億 USD | 1.83億 USD |
| 減価償却費と償却費 | 10.68億 USD | 11.19億 USD | 9.81億 USD | 7.1億 USD | 5.15億 USD |
| 営業利益 | 36.48億 USD | 30.4億 USD | 24.47億 USD | 27.52億 USD | 26.75億 USD |
| 純利益 | 15.54億 USD | 15.09億 USD | 17.45億 USD | 16.99億 USD | 15.4億 USD |
会社概要が更新されました 2026年10月8日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$358.14
上昇余地(12.49%)分割調整後の1株当たりの年間現金分配金。
$2.25
2025年(通年)-47.9% 以来 2021
2026年(一部):$1.80
$4.32
2,021
$1.865
2,022
$1.965
2,023
$2.08
2,024
$2.25
2,025
$1.80
2,026*
* 利用可能な配当履歴のうち、暦年の一部のみを含みます。
| 種別 | 配当落ち日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
配当 | 2026年8月14日 | $0.60Quarterly | 2026年8月14日 | 2026年8月31日 |
配当 | 2026年5月15日 | $0.60Quarterly | 2026年5月15日 | 2026年6月1日 |
配当 | 2026年2月13日 | $0.60Quarterly | 2026年2月13日 | 2026年3月2日 |
配当 | 2025年11月14日 | $0.60Quarterly | 2025年11月14日 | 2025年12月1日 |
配当 | 2025年8月15日 | $0.55Quarterly | 2025年8月15日 | 2025年9月3日 |
配当 | 2025年5月16日 | $0.55Quarterly | 2025年5月16日 | 2025年6月2日 |
配当落ち 2026年8月14日
$0.60
Quarterly
2026年8月14日基準 · 支払日 2026年8月31日
配当落ち 2026年5月15日
$0.60
Quarterly
2026年5月15日基準 · 支払日 2026年6月1日
配当落ち 2026年2月13日
$0.60
Quarterly
2026年2月13日基準 · 支払日 2026年3月2日
配当落ち 2025年11月14日
$0.60
Quarterly
2025年11月14日基準 · 支払日 2025年12月1日
配当落ち 2025年8月15日
$0.55
Quarterly
2025年8月15日基準 · 支払日 2025年9月3日
配当落ち 2025年5月16日
$0.55
Quarterly
2025年5月16日基準 · 支払日 2025年6月2日
この株式へのエクスポージャーを報告している上場投資信託です。
State Street SPDR S&P 500 ETF1557.T1166.17億0.09%129.41兆 JPY0.09%¥122,700-0.57%
Vanguard Morningstar Total Stock Market ETFVTI19.01億0.08%2.3兆 USD0.03%$379.42-0.42%
Vanguard S&P 500 ETFVOO16.73億0.10%1.8兆 USD0.03%$711.66-0.38%
Vanguard Morningstar Mid-Cap ETFVO12.94億0.57%2264億 USD0.03%$79.985-0.19%
iShares Core S&P 500 ETFIVV8.06億0.09%8996.25億 USD0.03%$777.67-0.37%
State Street SPDR S&P 500 ETFSPY7.37億0.09%8190.39億 USD0.09%$774.23-0.38%
Vanguard Morningstar Value ETFVTV5.71億0.22%2624億 USD0.03%$217.88-0.15%
State Street Health Care Select Sector SPDR ETFXLV4.25億0.99%431.09億 USD0.08%$165.61-1.90%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLVAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。